DYNO

The team needs more blockchain experience. Apart from the budget (page 38 of the WP) there should be more business planning numbers. No competitive analysis available// improved after checking the working project and their successful efforts to raise venture capital. I will recheck later again

Team ★★★★
Vision ★★★★★
Product ★★★★★

There is no business plan about the sensor and his impact on the market.
The team needs more experience on fundraising and blockchain projects.
I dont know how the investor can get roi, the sensor should be a standard on the market to get results.
I love the vision, as sportsman and sports businessman I can understand the potential of DYNO, but vision doesnt assure results.

EDITED
Rate improved after team response.

The innovation is solving a real problem and the analytics collected will be of true value to healthcare providers and insurers

The tokenomics is also well structured and when the business plan is duly executed, the value of tokens will be well supported.

The team is also robust with professionals in relevant fields.

Metabolism Analysis based on breathing gases surely has potential. Today's analysis models are much more expensive and need more effort than Dyno.

Although a Blockchain approach is not really needed, this Token might become valuable by leveraging the generated data.

As rightly said that "Health is Wealth", I am sure the future is bright for companies venturing into space. An ICO from existing company with existing product line is always beneficial but integrating blockchain data into the line can be challenging. Based on backing from strong team having an entrepreneurial experience and debt free books, i will give this company thumb up but KYC part is missing, which has to be addressed by the team. Token economics has been worked out carefully. Token burn mechanism can reduce the circulating supply post mass adoption and can thus boost token value for investors.

VISION: Interesting vision, although niche. There may be privacy issues, particularly in Europe. The ambition to dominate the market is probably strategically correct if it can be achieved. Although I am unsure that the blockchain will ensure that medical researchers get the correct type of high quality data that they need. 3/5

TEAM: A large team covering an extensive set of skills, though could use more than the two advisors listed to carefully navigate some complex issues. 4/5

PRODUCT: The MVP is available and the white paper is particularly clear which is good at this stage. 4/5

This is not an invitation to invest. ICOs are risky and you can lose everything you put in.

Dynostics caught my attention for having an existing business and product. After having an interaction with the team I would give them a very good rating based on the following reasons:

1- Dynostics is an existing company with a very useful product and growing sales
2- They have a very interesting B2B revenue model that provides them with a continuous cash flow
3- Their devices collect a unique set of biological markers that can be of interest not only to individuals but also to research institutes and insurance companies
4- By integrating the blockchain, they are giving users the data ownership and a possibility to monetize it

The team lack blockchain expertise. The hardware, itself, is a good product however the use of blockchain and a token is not mass market. The use case is far too specific for a singular device and is unlikely to gather mass adoption as per the current vision. This means that the number of users of this particular blockchain will have plenty of acquisition probelms considering there are plenty of data exchange and IoT products and other health tracking IoT devices out there.